Effect of carbamylated erythropoietin on major histocompatibility complex expression and neural differentiation of human neural stem cells

Journal of Neuroimmunology

Volumn 221, Issue 1-2, 2010, Pages 15-24

  Fu, Zhong Qiu ^a   Shao, Qing Liang ^a   Shen, Jing Ling ^a   Zhang, Yu Jing ^a   Zhao, Xia Xia ^a   Yao, Li ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Carbamylated erythropoietin; Cytokines; Graft rejection; Human neural stem cells; MHC antigens; Neurite outgrowth

Indexed keywords

CARBAMYLATED ERYTHROPOIETIN; ERYTHROPOIETIN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN KINASE B; STAT3 PROTEIN; STAT5 PROTEIN; UNCLASSIFIED DRUG; ANDROSTANE DERIVATIVE; CYTOKINE; DRUG DERIVATIVE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; HISTOCOMPATIBILITY ANTIGEN; IMMUNOSUPPRESSIVE AGENT; NERVE PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARTHENOLIDE; SESQUITERPENE; WORTMANNIN;

ANTIGEN EXPRESSION; ARTICLE; CELL FATE; CELL PROLIFERATION; CONTROLLED STUDY; FETUS; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEURAL STEM CELL; NEUROPROTECTION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; WESTERN BLOTTING; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; EMBRYONIC STEM CELL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHODOLOGY; NERVE CELL; NEURITE; PHYSIOLOGY;

ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; EMBRYONIC STEM CELLS; EPIDERMAL GROWTH FACTOR; ERYTHROPOIETIN; FETUS; FIBROBLAST GROWTH FACTOR 2; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HISTOCOMPATIBILITY ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; NERVE TISSUE PROTEINS; NEURITES; NEURONS; SESQUITERPENES;

EID: 77951235274     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.01.016     Document Type: Article

References (31)

1. Adembri C., Massagrande A., Tani A., Miranda M., Margheri M., De Gaudio R., Pellegrini-Giampietro D.E. Carbamylated erythropoietin is neuroprotective in an experimental model of traumatic brain injury. Crit. Care Med. 2008, 36:975-978.
2. Al Nimer F., Wennersten A., Holmin S., Meijer X., Wahlberg L., Mathiesen T. MHC expression after human neural stem cell transplantation to brain contused rats. Neuroreport 2004, 26:1871-1875.
3. Barker R.A., Widner H. Immune problems in central nervous system cell therapy. Neuro. Rx. 2004, 1:472-481.
4. Bowness P., Caplan S., Edidin M. MHC molecules lead many lives. Workshop on MHC class I molecules at the interface between biology & medicine. EMBO Rep. 2009, 10:30-34.
5. Bradbury M.S., Panagiotakos G., Chan B.K., Tomishima M., Zanzonico P., Vider J., Ponomarev V., Studer L., Tabar V. Optical bioluminescence imaging of human ES cell progeny in the rodent CNS. J. Neurochem. 2007, 102:2029-2039.
6. Cheng Y., King N.J., Kesson A.M. Major histocompatibility complex class I (MHC-I) induction by West Nile virus: involvement of 2 signaling pathways in MHC-I up-regulation. J. Infect. Dis. 2004, 189658-189668.
7. Digicaylioglu M., Lipton S.A. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signaling cascades. Nature 2001, 412:641-647.
8. Duan W.M., Westerman M., Flores T., Low W.C. Survival of intrastriatal xenografts of ventral mesencephalic dopamine neurons from MHC-deficient mice to adult rats. Exp. Neurol. 2001, 167:108-117.
9. Duan W.M., Westerman M.A., Wong G., Low W.C. Rat nigral xenografts survive in the brain of MHC class II-, but not class I-deficient mice. Neuroscience 2002, 115:495-504.
10. Genc S., Koroglu T.F., Genc K. Erythropoietin and the nervous system. Brain Res. 2004, 12:19-31.
11. Goddard C.A., Butts D.A., Shatz C.J. Regulation of CNS synapses by neuronal MHC class I. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:6828-6833.
12. Haylett R.S., Koch N., Rink L. MHC class II molecules activate NFAT and the ERK group of MAPK through distinct signaling pathways in B cells. Eur. J. Immunol. 2009, 39:1947-1955.
13. Huh G.S., Boulanger L.M., Du H., Riquelme P.A., Brotz T.M., Shatz C.J. Functional requirement for class I MHC in CNS development and plasticity. Science 2000, 290:2155-2159.
14. Johansson S., Price J., Modo M. Effect of inflammatory cytokines on major histocompatibility complex expression and differentiation of human neural stem/progenitor cells. Stem Cells 2008, 26:2444-2454.
15. King V.R., Averill S.A., Hewazy D., Priestley J.V., Torup L., Michael-Titus A.T. Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat. Eur. J. Neurosci. 2007, 26:90-100.
16. Leist M., Ghezzi P., Grasso G., Bianchi R., Villa P., Fratelli M., Savino C., Bianchi M., Nielsen J., Gerwien J., Kallunki P., Larsen A.K., Helboe L., Christensen S., Pedersen L.O., Nielsen M., Torup L., Sager T., Sfacteria A., Erbayraktar S., Erbayraktar Z., Gokmen N., Yilmaz O., Cerami-Hand C., Xie Q.W., Coleman T., Cerami A., Brines M. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 2004, 305:239-242.
17. Liao Z.B., Zhi X.G., Shi Q.H., He Z.H. Recombinant human erythropoietin administration protects cortical neurons from traumatic brain injury in rats. Eur. J. Neurol. 2008, 15:140-149.
18. Liu X., Ye L., Bai Y., Mojidi H., Simister N.E., Zhu X. Activation of the JAK/STAT-1 signaling pathway by IFN-γ can down-regulate functional expression of the MHC class I-related neonatal Fc receptor for IgG. J. Immunol. 2008, 181:449-463.
19. Moretta L., Bottino C., Cantoni C., Mingari M.C., Moretta A. Human natural killer cell function and receptors. Curr. Opin. Pharmacol. 2001, 1:387-391.
20. Oliveira A.L., Thams S., Lidman O., Piehl F., Hokfelt T., Karre K., Linda H., Cullheim S. A role for MHC class I molecules in synaptic plasticity and regeneration of neurons after axotomy. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:17843-17848.
21. Sanchez P.E., Navarro F.P., Fares R.P., Nadam J., Georges B., Moulin C., Le Cavorsin M., Bonnet C., Ryvlin P., Belmeguenai A., Bodennec J., Morales A., Bezin L. Erythropoietin receptor expression is concordant with erythropoietin but not with common beta chain expression in the rat brain throughout the life span. J. Comp. Neurol. 2009, 514:403-414.
22. Savino C., Pedotti R., Baggi F., Ubiali F., Gallo B., Nava S., Bigini P., Barbera S., Fumagalli E., Mennini T., Vezzani A., Rizzi M., Coleman T., Cerami A., Brines M., Ghezzi P., Bianchi R. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis. J. Neuroimmunol. 2006, 172:27-37.
23. Schmidt R.E., Green K.G., Feng D., Dorsey D.A., Parvin C.A., Lee J.M., Xiao Q., Brines M. Erythropoietin and its carbamylated derivative prevent the development of experimental diabetic autonomic neuropathy in STZ-induced diabetic NOD-SCID mice. Exp. Neurol. 2008, 209:161-170.
24. Sirén A.L., Fratelli M., Brines M., Goemans C., Casagrande S., Lewczuk P., Keenan S., Gleiter C., Pasquali C., Capobianco A., Mennini T., Heumann R., Cerami A., Ehrenreich H., Ghezzi P. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:4044-4049.
25. Sirén A.L., Fasshauer T., Bartels C., Ehrenreich H. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics 2009, 6:108-127.
26. Stampachiacchiere B., Aloe L. Differential modulatory effect of NGF on MHC class I and class II expression in spinal cord cells of EAE rats. J. Neuroimmunol. 2005, 169:20-30.
27. Villa P., van Beek J., Larsen A.K., Gerwien J., Christensen S., Cerami A., Brines M., Leist M., Ghezzi P., Torup L. Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives. J. Cereb. Blood Flow Metab. 2007, 25:52-63.
28. Wang L., Zhang Z.G., Gregg S.R., Zhang R.L., Jiao Z., LeTourneau Y., Liu X., Feng Y., Gerwien J., Torup L., Leist M., Noguchi C.T., Chen Z.Y., Chopp M. The Sonic hedgehog pathway mediates carbamylated erythropoietin-enhanced proliferation and differentiation of adult neural progenitor cells. J. Biol. Chem. 2007, 2:32462-32470.
29. Wennersten A., Holmin S., Al Nimer F., Meijer X., Wahlberg L.U., Mathiesen T. Sustained survival of xenografted human neural stem/progenitor cells in experimental brain trauma despite discontinuation of immunosuppression. Exp. Neurol. 2006, 199:339-347.
30. Yiγ U., Kurul S.H., Kumral A., Tuγyan K., Cilaker S., Yilmaz O., Genç S., Genç K. Effect of erythropoietin on oxygen-induced brain injury in the newborn rat. Neurosci. Lett. 2008, 448:245-249.
31. Yoshimura S., Bondeson J., Foxwell B.M., Brennan F.M., Feldmann M. Effective antigen presentation by dendritic cells is NF-κB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines. Int. Immunol. 2001, 13:675-683.